Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Maintain ADD on Tata Consultancy Services - Stellar performance continues - HDFC Securities

Posted On: 2021-01-12 03:15:18 (Time Zone: Arizona, USA)


We maintain ADD on TCS, following a back-to-back stellar performance and positive commentary. Key positives included (1) broad-based (verticals & services) growth outperformance (strongest 3Q in nine years) supported by better conversions, (2) robust deal wins with TCV at USD 6.8bn (ex-PBS Deutsche deal), 9MFY21 TCV higher by 23% and strong bookings/ramp-up expected in 4Q, (3) margin outperformance supported by operating leverage & efficiencies. Management provided 'double-digit' outlook for FY22/CY21 (we have factored in 14.8% for FY22E) and 'sustainability of momentum' for 3-5 years secular cycle of cloud adoption. Strong outlook for BFSI vertical (strongest-ever BFSI deal bookings), investments in hyperscalers units, improving supply-side metrics (stronger linkages with revenue growth and an uptick in contextual masters), and lowest-ever attrition were other highlights. Our target price of Rs 3,435 is based on 28x Dec-22E EPS (27x earlier) with EPS CAGR at 19% over FY21-23E.

3QFY21 highlights: (1) Revenue came at the highest ever 3Q in the past nine years at 4.1% QoQ CC (0.4% YoY). (2) EBIT margin hit a 19-quarter high at 26.6%, +42bps QoQ supported by operating leverage and FX tailwind, which offset the negative impact of salary hike (-160bps QoQ). (3) Net additions included 1,500 from Pramerica Ireland (Prudential) and 12,000 trainees were onboarded in 3Q. (4) BFSI and Retail & CPG verticals grew 2% QoQ and 3.1% QoQ in CC terms and BFSI growth ex-seasonality impact was similar to 2Q.

Outlook: TCS' gold standard in execution/scale will be supported by industry tailwind of strong tech cycle. We have factored in USD revenue growth of 0.4%, 14.8%, 10.7% for FY21/22/23E with 4QFY21 at 3.9% QoQ. EBIT margin for TCS factored at 26.8%, 27.3% for FY22/23E. Valuations are at 28.4/24.6x with FY21-23E EPS CAGR at 19%.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.3175.05 as compared to the previous close of Rs. 3120.35. The total number of shares traded during the day was 253600 in over 18332 trades.

The stock hit an intraday high of Rs. 3224 and intraday low of 3147.45. The net turnover during the day was Rs. 804977931.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Can Fin Homes Ltd Q3 FY2020-21 net profit up at Rs. 131.91 crore

Genus Paper & Boards Ltd Q3FY21 net profit at Rs. 4.15 crore

Chennai Petroleum Corporation Ltd Q3FY21 consolidated loss at Rs. 546.41 crore

Sharda Cropchem Ltd Q3FY21 consolidated PAT jumps to Rs. 48.30 crore

Natural Capsules Ltd reports consolidated PAT of Rs. 1.62 crore in Q3FY21

TGV Sraac Ltd reports lower Q3FY21 net profit of Rs. 9.85 crore

Aarti Drugs Ltd Q3FY21 consolidated PAT drops QoQ to Rs. 68.04 crore

Lakshmi Electrical Control Systems Ltd Q3FY21 net profit at Rs. 0.0875 crore

PG Electroplast Ltd Q3FY21 net profit rises to Rs. 6.49 crore

Kirloskar Ferrous Industries Ltd Q3 net profit jumps to Rs. 118.32 crore

Stylam Industries Ltd reports Rs. 12.46 crore consolidated PAT in Q3FY21

Vinyl Chemicals India Ltd posts Rs. 4.83 crore PAT in Q3 FY2020-21

APL Apollo Tubes Ltd Q3FY21 consolidated PAT higher at Rs. 132.04 crore

Thomas Cook India inks strategic agreement with Destination Maldives

PNC Infratech Limited receives LOAs for Six New Rural Drinking Water Supply Projects on EPC mode for an aggregate value of Rs. 2475.00 crore

Arihant Capital Markets Ltd posts consolidated PAT of Rs. 8.94 crore in Q3FY21

Kotak Mahindra Bank posts Rs. 2575.74 crores consolidated PAT in Q3 FY2020-21

Shri Jagdamba Polymers Ltd Q3 net profit jumps to Rs. 11.35 crore

UCO Bank Q3FY21 PAT at Rs. 35.44 crore

DCW Limited board approves fund raising through warrants

Lupin Receives approval for Sevelamer Carbonate Tablets

Strides receives USFDA approval for Ursodiol Capsules

Kiri Industries Limited starts commercial production of Specialty Intermediates at Vadodara Palnt

Bannari Amman Spinning Mills Ltd board approves stock split, CDR

Padget Electronics to commence manufacturing of Nokia smartphones as HMD Global's manufacturing partners

Zydus' Desidustat shows efficacy and safety in treating Hypoxia in hospitalized Covid-19 patients in Mexico

Wipro recognised as Top Employer 2021 in Australia for the second consecutive year

Antony Waste Handling Cell Ltd updates on business during Q3 FY21

Tiaan Consumer Limited Signs Up as a Beauty Partner for Safe Speed Challenge

R S Software India Ltd posts loss of Rs. 5.11 crore in Q3FY21

NCL Industries Ltd to set up 2000 TPD cement grinding unit

Riba Textiles Limited to expand capacity

United Spirits Limited to sell its stake in Tern Distilleries Pvt Ltd for Rs. 30 crore

Hinduja Global Solutions Limited arm raises stake in HGS Digital LLC to 100%

Adani Green Energy Signs Agreement to Acquire 20 MW Operating Solar Asset for INR 133 cr

Steel Exchange India Limited receives OTS sanction letters from all lenders

DCB Bank Ltd posts Q3FY21 net profit of Rs. 96.21 crore

Vivanza Biosciences Ltd posts consolidated PAT of Rs. 0.16 crore in Q3

Arihant Superstructures Ltd Q3FY21 consolidated net profit at Rs. 1.94 crore

ICRA reaffirms rating of IIFL Finance Ltd, IIFL Home Finance Ltd

Zenotech Laboratories Ltd appoints Mr. Devendra Chandrakant S. Kenkre as CEO

Polycab India Ltd reports Q3FY21 consolidated PAT of Rs. 262.50 crore

JM Financial Ltd posts consolidated PAT of Rs. 180.76 crore in Q3 FY2020-21

Birla Corporation Ltd Q3FY21 consolidated PAT at Rs. 148.42 crores

Sportking India Ltd Q3 net profit zooms to Rs. 30.32 crore

APM Finvest Ltd Q3FY21 net profit jumps to Rs. 6.90 crore

Ultratech Cement Ltd reports jump in Q3FY21 consolidated PAT to Rs. 1584.34 crores

Supreme Industries Ltd Q3FY21 Q3FY21 consolidated PAT zooms to Rs. 312.28 crore

Mahindra Lifespaces achieves residential sales of Rs. 195 crores during Q3FY21 up 70% over Q2FY21

Rossari Biotech Ltd Q3FY21 consolidated PAT up at Rs. 21.60 crore



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020